PMC:7558914 / 21436-21601
Annnotations
LitCovid-PubTator
| Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
|---|---|---|---|---|---|
| 534 | 121-129 | Species | denotes | patients | Tax:9606 |
| 538 | 73-91 | Chemical | denotes | methylprednisolone | MESH:D008775 |
| 552 | 142-150 | Disease | denotes | COVID-19 | MESH:C000657245 |
| 553 | 155-159 | Disease | denotes | ARDS | MESH:D012128 |
LitCovid-sentences
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T138 | 0-165 | Sentence | denotes | Based on this fact, a recently published guideline suggested using 40 mg methylprednisolone intravenously for 10 days in patients with severe COVID-19 and ARDS [22]. |